reference/18884188

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18884188

Outgoing Links

Predicate	Object
contentType	Case Reports\|Journal Article
endingPage	1487
issn	1933-2874
issueIdentifier	6
pageRange	1485-1487
publicationName	Journal of Clinical Lipidology
startingPage	1485
bibliographicCitation	Shakir MKM, Shin T, Hoang TD, Mai VQ. Successful treatment of a patient with statin-induced myopathy and myotonic dystrophy type II with proprotein convertase subtilisin/kexin type 9 inhibitor, alirocumab (Praluent). Journal of Clinical Lipidology. 2017 Nov;11(6):1485–7. doi: 10.1016/j.jacl.2017.08.014.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c5659a09e5a5385b330aff2d4e3ec48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52462731e215a264cd343226a6f1456a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e26840979364c7aec5539b05b4ae2aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2473ac0146e0472203068265db563ce1
date	201711
identifier	https://pubmed.ncbi.nlm.nih.gov/29056268 https://doi.org/10.1016/j.jacl.2017.08.014
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33818 https://portal.issn.org/resource/ISSN/1933-2874
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Successful treatment of a patient with statin-induced myopathy and myotonic dystrophy type II with proprotein convertase subtilisin/kexin type 9 inhibitor, alirocumab (Praluent)
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0572338 http://id.nlm.nih.gov/mesh/M0447016 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M000614708 http://id.nlm.nih.gov/mesh/M0012591 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009135Q000188 http://id.nlm.nih.gov/mesh/D000071449Q000235 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D009223Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009135Q000473 http://id.nlm.nih.gov/mesh/D008078Q000097 http://id.nlm.nih.gov/mesh/D009135Q000235 http://id.nlm.nih.gov/mesh/D009223Q000139 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D019161Q000009 http://id.nlm.nih.gov/mesh/D009135Q000139 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009223Q000473 http://id.nlm.nih.gov/mesh/D009223Q000235 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.3.2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8122 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114162 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87071853 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883735 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150311 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8066 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8544 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47d076e180ade31f7985c0914d943f8b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9869776 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11437 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID303 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8576 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439520 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12086784

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID255738

Total number of triples: 66.